Krka Spells Out Chinese Potential With Plans To Double Portfolio In 2022

Slovenian Firm Also Plans To Regroup In West Europe After 11% Sales Tumble

China growth
Krka launched pregabalin in China in 2021 • Source: Shutterstock

More from Earnings

More from Business